Cordlife Secures One-Year Renewal of Service License; Shares Surge 19%
MT Newswires
Jan 14
Cordlife (SGX:P8A) secured a one-year renewal of its cord blood banking service license, according to a Wednesday filing with the Singapore Exchange.
The company also received a two-year renewal for its human tissue banking service license from Jan. 14 to Jan. 13, 2028.
Under the conditions of the renewal of the two licenses, the company cannot collect, test, process and store CBUs from infant donors and is also required to replace its clinical governance officer and hire a suitable replacement.
Meanwhile, the company is also required to retrain its laboratory personnel.
Shares of the company surged nearly 19% in Wednesday trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.